Speaker: 

Stan Tokachjov, MD, Ephipany Dermatology/Mohs Surgeon- has disclosed the following financial relationships:
Misonix/Bioventus/Barco/Merck- former speaker
Castle Biosciences - Investigator/Speaker
Kerecis/Boehringer Ingelheim- Speaker
Illumisonics- Clinical Advisory Board

Speaker/Moderator:

Michael Ramsey, MD, Staff Member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • Expand and review treatment options for benign and malignant skin cancer.
  • Improve clinicopathologic correlation.
  • Evaluate a perioral defect and recommend a reconstructive option.
  • Design a Burow's advancement flap or its analogues in the perioral area.
  • Recognize and diagnose common and uncommon neutrophilic dermatoses.
  • Develop and recommend a treatment plan for neutrophilic dermatoses, especially pyoderma gangrenosum.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Eric W. Hossler, MD and Ashley Hubal, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose.
Tammy McCormick, RDN, LDN, CDE; Timothy Murphy, MD; Michaelyn Notz, DO and Dean Parry, RPh
 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None 

Session date: 
03/22/2024 - 8:00am to 1:00pm EDT
Location: 
Dermatology Woodbine
Danville, PA
United States
  • 5.00 AAPA Category I CME
  • 5.00 AMA PRA Category 1 Credit
  • 5.00 Participation Credit

Please login or register to take this course.